Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

3.62
BATS BZX Real-Time Price
As of 11:24am ET
 -0.07 / -1.90%
Today’s Change
1.65
Today|||52-Week Range
4.69
+44.80%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close3.69
Today’s open3.65
Day’s range3.59 - 3.69
Volume2,620
Average volume (3 months)212,868
Market cap$75.8M
Dividend yield--
Data as of 11:24am ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+9.64%
Earnings growth (this year)+42.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+105.25%
P/E ratioNM
Price/Sales1.60
Price/Book10.95

Competitors

 Today’s
change
Today’s
% change
AVEOAveo Pharmaceuticals...-0.00-0.42%
EGLTEgalet Corp-0.08-2.95%
RGLSRegulus Therapeutics...+0.07+5.45%
NAVBNavidea Biopharmaceu...+0.00+0.49%
Data as of 11:20am ET, 05/23/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$19.9M
Annual profit (last year)-$19.1M
Net profit margin-95.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Chief Operating Officer
Clayton D. Edwards
Corporate headquarters
San Diego, California

Forecasts